| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.52B | +60.6% |
| Cost of Revenue | $1.04B | +88.9% |
| R&D Expense | $163.8M | +32.0% |
| SG&A Expense | $981.0M | +52.5% |
| Operating Income | $166.0M | +24.7% |
| Pre-tax Income | $120.7M | -27.0% |
| Income Tax | $17.7M | -58.3% |
| Net Income | $103.0M | -16.2% |
| EPS (Basic) | $0.76 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $105.6M | +109.2% |
| Accounts Receivable | $557.7M | +10.8% |
| Inventory | $659.2M | -22.3% |
| Current Assets | $2.18B | +13.7% |
| Total Assets | $5.25B | +3.3% |
| Current Liabilities | $855.9M | +118.2% |
| Total Liabilities | $1.07B | -1.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $520.6M | +113.8% |
| Capital Expenditures | $115.4M | +47.5% |
| Investing Cash Flow | -$176.1M | -158.1% |
| Financing Cash Flow | -$27.7M | +88.1% |
| Free Cash Flow | $405.2M | +145.2% |
| -30.3% |
| EPS (Diluted) | $0.75 | -29.9% |
| Stockholders' Equity |
| $4.18B |
| +4.5% |